We are a biotech company combining microfluidics, digitalization and bioengineering to make high quality biological therapies at affordable cost and minimized environmental impact. Therapeutic cells can multiply in the patient`s body. This allows high purity miniature doses cellular therapies to expand in vivo up to the amounts needed to obtain therapeutic effects. Leveraging this specificity, our approach consists in optimizing and miniaturizing cellular therapies and their manufacturing. This way minute amounts of resources are spent without compromising efficacy. As a result costs and environmental impact of these innovative therapies are drastically reduced.